Unique Discount Offer on Pharma Country Series by GlobalData Now Available at MarketPublishers.com
04 Dec 2013 • by Natalie Aster
LONDON – Market Publishers Ltd is pleased to announce a unique discount offer on Pharma Country Series provided by GlobalData.
Buy the complete bundle (per sector) of in-demand pharma country reports and receive 50% OFF! Or purchase any 3 pharma country reports and get 35% OFF! Alternatively, place an order for a single pharma country report and receive 20% OFF!
Stay ahead of the constantly intensifying competition by gaining a clear understanding of the changing landscape in the pharma marketplace with the help of GlobalData research reports currently available at discounted prices!
Pharma Markets Research Reports on Offer Include but Are Not Limited to:
- PharmaPoint: Alzheimer’s Disease - UK Drug Forecast and Market Analysis to 2022
- PharmaPoint: Non-Small Cell Lung Cancer - UK Drug Forecast and Market Analysis to 2022
- PharmaPoint: Dry Eye Syndrome - Spain Drug Forecast and Market Analysis to 2022
- PharmaPoint: Chronic Heart Failure - Germany Drug Forecast and Market Analysis to 2022
- PharmaPoint: Psoriasis - Italy Drug Forecast and Market Analysis to 2022
- PharmaPoint: Meningococcal Vaccines - France Drug Forecast and Market Analysis to 2022
- PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis to 2022
- PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
- PharmaPoint: Osteoporosis - Spain Drug Forecast and Market Analysis to 2022
- PharmaPoint: HIV - Italy Drug Forecast and Market Analysis to 2022
These discounted research reports present in-depth guides to various sectors of the pharma industry for different countries. Each research study offers an insightful analysis of the examined market and discloses essential historical and present data on the respective country’s industry performance. Each report offers a comprehensive discussion on the particular disease, including the important information on its epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. The research studies contain detailed competitive assessments, profile major companies active in the respective markets, and give snapshots of existing products. The reports outline the main market opportunities and examine the unmet needs, include pertinent diseases’ drug pipeline analyses and SWOT analyses, scrutinize key factors driving and restraining the markets’ growth. In addition, market forecasts along with top drugs’ sales projections up to 2022 are offered in the research studies.
The offer ends December 30, 2013!
For a full list of GlobalData research studies on offer, please click here.
CONTACTS
The Market Publishers, Ltd.
Tanya Levdikova
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com
Analytics & News
